GlassScriptPhysician profile
Michael A Tillery
NPI 1558725580
$19,420.21
in general payments reported to CMS, 2019-2025
29 companies · $1,518 in 2025
The $1,518 reported for 2025 was more than what 87% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,982 · 2022: $12K · 2023: $1,731 · 2024: $864 · 2025: $1,518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,637 · Travel and Lodging: $1,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,636.93 |
| Travel and Lodging | $1,476.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $14,584.72 | 2021-2025 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $1,428.29 | 2024-2025 | Optimizer |
| Medtronic, INC. | $1,270.23 | 2021-2025 | Linq II |
| Novartis Pharmaceuticals Corporation | $475.17 | 2021-2025 | |
| Amgen INC. | $257.48 | 2021-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.85 | 2021-2024 | Jardiance |
| Abbott Laboratories | $144.81 | 2023-2025 | Jot Dx, Aveir, Gallant |
| Biotronik INC. | $139.40 | 2023 | Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $130.06 | 2021-2025 | Watchman, Watchman Access System |
| Biosense Webster, INC. | $99.34 | 2024 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $90.46 | 2021-2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $82.13 | 2023-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $57.89 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $56.92 | 2023 | |
| Irhythm Technologies, INC. | $53.00 | 2021-2024 | Zio Monitor, Zio Xt Patch |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $52.91 | 2021-2023 | Brilinta |
| Scpharmaceuticals INC. | $47.80 | 2024-2025 | |
| Philips North America LLC | $36.07 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $33.95 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $31.70 | 2022-2024 | Nexletol |
| Merck Sharp & Dohme LLC | $29.71 | 2022 | |
| Novo Nordisk INC | $26.77 | 2022 | |
| Edwards Lifesciences Corporation | $23.41 | 2024 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.62 | 2021-2024 | Lifevest |
| Alnylam Pharmaceuticals INC. | $20.12 | 2023 | Onpattro |
| Kestra Medical Technology Services, INC. | $16.69 | 2024 | Assure Wcd |
| Amarin Pharma, INC. | $15.33 | 2022 | |
| Cardiovascular Systems INC. | $14.14 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tillery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.